[{"Assets_0_Q1_USD":1774669000.0,"EarningsPerShareBasic_1_Q1_USD":0.66,"EarningsPerShareDiluted_1_Q1_USD":0.64,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-1113000.0,"NetIncomeLoss_1_Q1_USD":35539000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":19801000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":616219000.0,"StockholdersEquity_0_Q1_USD":799128000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":55959000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":53997000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES INC","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20180427"}]